HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Ind-Swift Laboratories to incorporate wholly owned subsidiary in UAE
Apr-19-2024

Ind-Swift Laboratories has received approval to incorporate wholly owned subsidiary (WOS) in Dubai, United Arab Emirates (UAE) in the name and style of ‘Ind-Swift (Dubai)’ or such other name as may be approved by the concerned authorities of the UAE. 

The WOS intends to strategically invest in pharmaceutical and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units. The investment in the wholly owned subsidiary would be a Related Party Transaction. The investment shall be made on arms’ Length basis.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


  RELATED NEWS >>